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Abstract 
 
The Royal Commission on Genetic Modification (2000 – 2001) was a major exercise in the 
construction of ‘scientific citizenship’ in Aotearoa/New Zealand. It was closely followed by a 
general election in which state regulation of genetic modification was a significant issue. In the 
aftermath of intensive public discussion about the utilization of new biotechnologies and the 
development of a national biotechnology strategy, the state is investing in research directed at 
dialogic approaches to debates about new technologies. This paper reflects on these initiatives 
and analyses the challenges confronting those experimenting with interventions directed at 
dialogic discussion between Māori and non-Māori members of community organisations, 
scientists, clinicians, policy-makers, lobby groups and actors in the biotechnology industry. It 
explores the ways in which participatory processes pioneered in Scandinavia, Canada, the UK 
and Europe are being modified in the New Zealand context and reflects on the possibility of 
developing New Zealand-specific strategies for effecting ‘scientific citizenship’.  
 
                                                 
1 This paper is informed by discussion with members of the ‘Constructive Conversations’ research team 
and their contributions to project proposals, memos, discussion documents and methodological strategies. 
They include: Anne Scott, Joanna Goven, Bevan Tipene-Matua, Andrew Moore, Jane Gilbert, Rose 
Hipkins, Rachel Bolstad, Robyn Baker, Fiona Cram, Murray Parsons, Trina Taupo, Jan Crosthwaite, 
Gareth Jones and Lesley MacGibbon. Barbara Nicholas, Geoff Fougere, Bronwyn Hayward, Julie 
Wuthnow, Hugh Campbell, Brian Wynne and Jack Heinemann have also contributed directly and indirectly 
to this paper. However, none of the above is responsible for the specific paper presented at this conference. 
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The possibility of ‘scientific citizenship’ 
 
‘…active citizenship is a pervasive discourse in many contemporary societies, providing 
the framework for many discussions about genetic technologies and their purported 
benefits, as well as the rationale for diverse programmes and practices’ (Petersen and 
Bunton, 2002: 204). 
 
Against the background of significant public controversy about the development and 
application of genetic modification technologies in Aotearoa/New Zealand, the Royal 
Commission on Genetic Modification produced a four-volume report (Royal Commission 
on Genetic Modification, 2001). Increased Government funding for social research into 
the social, cultural, ethical and spiritual impacts of new biotechnologies was one of its 
many recommendations.  I coordinate a five-year, $3 million (NZ) project that is one of 
the recent beneficiaries of that recommendation. This paper explores the context in which 
that research is located and the global and local issues confronting that multi-ethnic, 
multi-disciplinary and multi-sited team. 
 
The ‘Constructive Conversations’ project is directed at enhancing public participation in 
decision-making about emerging health biotechnologies. It will analyse what members of 
community organisations have to say about the social issues associated with these 
technologies. Another key objective is to explore the ethical reasoning associated with 
discussion of technologies like genetic testing, embryonic stem cell research and bio-
nanotechnology. Crucial to the project is attention to Māori definitions of the issues 
associated with emerging health biotechnologies (ERMA, 1999; Cram, 2000) and the use 
of Māori conversational strategies in facilitating talk about these issues.  
 
The project embraces the possibility that people’s positions on certain public issues can 
change as a consequence of exposure to the arguments of others and/or information that 
was not previously available. (This includes the possibility that scientists and policy 
makers’ views might change in the light of access to public understandings of the impacts 
of particular biotechnologies). While the focus or this project is on New Zealand 
strategies for engaging diverse public actors in discussion of emerging health 
biotechnologies, it is one of many global interventions directed at constructing what Alan 
Irwin has referred to as ‘scientific citizenship’ (Irwin, 2001).  
 
Constructing public participation in science and technology decision-making 
 
In the face of public activism around GE foods, the BSE crisis and citizen skepticism 
about the statements of politicians and scientists, governments and science organisations 
in a number of social democracies have embraced the need for more public dialogue 
about scientific controversies (See for example: Royal Commission on Environmental 
Pollution (RCEP), 1998; Klüver, 1999; House of Lords Select Committee, 2000; 
Advisory Group to the Office of Science and Technology, 1999; EUROPTA, 2000; 
Royal Commission on Genetic Modification, 2001; Human Genetics Commission, 2003). 
Social democracies like the UK, Canada, Denmark, the Netherlands and New Zealand 
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have, to some degree at least, acknowledged that better decisions will be made if citizens 
are involved in deliberation about the use of new technologies.  
 
While these moves extend opportunities for engagement by civil society in issues about 
the development and use of emerging biotechnologies, it is important not to overestimate 
the continuing power of governments and scientific expertise. According to the UK’s 
Royal Commission on Environmental Pollution (RCEP), ‘drawing on a pool of 
knowledge and understanding (lay as well as professional) can give warning of obstacles 
that, unless removed or avoided, would impede effective implementation of a particular 
decision’ (Royal Commission on Environmental Pollution, 1998: 102).  Government 
agencies are often interested in including people in debates about new science who do not 
have ‘preconceived views’ on scientific controversies. This can lead to the exclusion 
from consultative processes of groups that are key stakeholders in discussion of scientific 
controversies. Strategies to engage ‘the public’ may generate initiatives that are primarily 
organised around ‘informing’ the citizens and restoring confidence in science, rather than 
fostering critical engagement with science and technology issues (Irwin, 2000). The 
effect of these processes can be an erosion of democratic principles, rather than an 
enhancement of democratic decision-making (Glasner, 2000). 
 
 In the UK, the RCEP report was closely followed by the Public Consultation on the 
Biosciences for the Office of the Science and Technology (1999), and the House of Lords 
Select Committee report on Science and Society (2000) that advocated higher levels of 
public participation in the development of science policy and the necessity of attending to 
public values and ethical concerns. The arguments advanced in the Science and Society 
report, and the UK Royal Society Science in Society Programme (The Royal Society, 
2003), have influenced position statements on science and society dialogue developed by 
officials in the New Zealand Ministry of Research, Science and Technology (MoRST, 
2001; 2002a; 2002b).  
 
Involvement in consultation processes about genetic modification and other new 
technologies is increasingly defined as a responsibility of citizens, and scientific 
organisations now invite them to actively engage with scientists in science-focused 
discussion. Alan Petersen and Robin Bunton discuss the construction of the ideal of the 
‘scientifically literate’ citizen who is ‘actively involved in issues associated with their 
own health and well-being’ (Petersen and Bunton, 2002: 185). “Talk to us” invites the 
UK Royal Society with web pages that invite responses to the question ‘Would you want 
a genetic test to tell you if you’re at risk of developing a disease’ (The Royal Society, 
2003)? 
 
Global shifts in the responses of governments and scientific organisations to science and 
technology politics and increasingly dissatisfaction with conventional democratic 
processes (Renn et al, 1995) constitute the context for the ‘Constructive Conversations’ 
research programme. But New Zealand experimentation with participatory and learning-
based strategies with respect to responses to new technologies also informs this research 
(Fitzgerald, 1999; Office of the Parliamentary Commissioner for the Environment, 2000; 
Harmsworth, 2001; Allen and Kilvington, 2002). Assessment of the implementation of 
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the Danish consensus conference model in New Zealand has also had a significant impact 
on the ‘Constructive Conversations’ project (Goven, forthcoming). This Danish model 
for public participation (Andersen and Jaeger, 1999) has been used all over the world to 
facilitate public discussion of science and technology (Joss and Durant, 1995; Joss, 1998; 
Guston, 1999). It was utilized in New Zealand in 1996, and again in 1999, to explore 
public responses to social, cultural and ethical issues associated with plant biotechnology. 
 
While appreciative of the goals of those who ran the New Zealand consensus 
conferences, her research has convinced Joanna Goven, a key member of the 
‘Constructive Conversations’ team, that attempts at dialogue can perpetuate old 
inequalities between participants and consolidate differences between ‘lay’ panelists and 
‘experts’, even in environments that are dedicated to public participation and deliberative 
democracy (Goven, forthcoming).  
 
Goven is wary of forms of public engagement that potentially constitute participants as 
lacking knowledge, rather than people with the knowledge necessary for effective 
deliberation about the social, ethical, cultural and spiritual implications of 
biotechnologies. This is consistent with Alan Petersen and Robin Bunton’s assertions 
about the dominance of the voice of the expert in situations in which the impact of new 
technologies is being debated (Petersen and Bunton, 2002: 180). They argue for attention 
to the need to involve diverse publics in decisions about applications of genetic 
technologies and suggest that there has been little attention to the ‘diverse and often 
complex views and responses of actual or potential ‘consumers’ of new technologies.  
 
Constructing accountability 
 
Why present this paper at a Policy and Politics conference rather than a Science and 
Technology Studies, or Biotechnology, or Science and Society conference? And why 
present it as the researchers embark on the piloting of the first set of focus groups rather 
than when we have some ‘data’ to present? The answers to these questions lie in the need 
for ongoing critical reflexivity as the research team simultaneously seeks to create 
opportunities for deliberative democracy, but also to critique these interventions and 
engage with the conditions that have facilitated funding for this research. These are key 
issues to debate at a policy and politics conference.  
 
Having embraced the responsibility to conduct research on how diverse publics can be 
involved in decisions about new health biotechnologies; this research team inevitably 
encounters the tension between policy and politics. For this reason we need feedback 
from other social researchers about our research processes and about our simultaneous 
positioning as researchers, and as those who are engaged in interventions in the 
community networks whose members will participate in this research. We need critical 
comment throughout the project, not just when we present our accounts of the outcomes 
of this research. We are both protagonists, evaluators and analysts, and the success of our 
project requires multiple sites of accountability: to our participants, to our funders, to the 
scientific community, to policy agencies, to the biotechnology industry, and to other 
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researchers who also embrace the risks and possibilities of doing research directed at 
democratic participation in issues of public policy.  
 
At the heart of policy and politics has been decision-making about the ways in which 
science and technology are to be utilized.2 Public decision-making about energy, 
transport, communications, fossil fuel, housing, mining, clean air, fishing, global 
warming, agriculture, health care, and the development and use of weapons are at the 
crux of political processes. Current political debate about genetically modified food, 
cloning, the Human Genome Project and gene patenting has meant that previously 
implicit links between policy, politics, science and technology are now explicit (Laird, 
1993; Irwin & Wynne, 1996; Grove-White et al, 1997; Mayer, 1997; Wellcome Trust, 
1998; Tesh, 2000; Wynne, 2001).  
 
This project addresses the connections between worlds that have often been kept 
separate, including artificial professional boundaries between social scientists working in 
the fields of social policy and those engaging in science policy. Issues relating to levels of 
participation and opportunities for public influence at the local, regional and international 
levels are pertinent for researchers engaged with science policy and those whose fields 
are housing, poverty, education, health and local government. We share with those 
engaged in social policy and community research the challenges of embracing the 
possibilities of change and the potential cooptation by government agencies that arises 
out of engagement with the policy process. 
 
Constructive Conversations – a new research programme 
 
‘Constructive Conversations: New biotechnologies, dialogue and informed decision-
making’ is an exercise in deliberative democracy involving both non-Māori and Māori 
(the tangata whenua, or indigenous people of Aotearoa/New Zealand). It is informed by 
Māori cultural conventions for engaging in conversation about issues of controversy 
(Metge, 2001). It also draws on international and local experience of focus groups, 
consensus conferences, panels and dialogic workshops directed at involving members of 
the public in discussion about science and technology. Attention to genetic testing 
preceded the release of the UK Genetics White Paper, released in June 2003 (Department 
of Health, 2003), but will usefully occur alongside consultation in the UK on the place of 
gene technologies in the NHS. 
 
The research methodology developed for this project, under the leadership of Anne Scott, 
a sociologist at University of Canterbury, involves reconvened focus groups with 
members of community organisations, website discussions, and interviews with key 
actors: scientists, clinicians, policy makers, lobby group representatives, politicians and 
representatives of biotech companies.  These interviews and conversations will precede 
day long-workshops that bring together research participants for discussion of issues 
arising out of reconvened focus groups, website discussions and interviews. The final 
stage of the project involves talking to policy makers about the relevance of the findings 
of the project for their work. Andrew Moore, a philosopher at Otago University, is 
                                                 
2 I am grateful to Geoff Fougere for discussion of this insight. 
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responsible for a significant component of the research - an inquiry into the explicit and 
implicit ethical reasoning about new biotechnologies used by participants in the study and 
by the authors of documents relating to science and technology policy. 
 
The project received its first installment of funding in April of 2003, and has been 
involved in planning the first focus groups.3 We have been scoping the range of 
community organisations that will be involved, including a variety of Māori community 
networks organised around tribal or iwi affiliations, religious connections, health 
practitioner networks, youth organisations, non-tribal community networks and expertise 
in public policy.  
 
One of our core concerns as a team of Māori and non-Māori researchers is how we can 
conduct our meetings in ways that respect and incorporate Māori cultural practices such 
as powhiri (welcome that recognizes the distinction between the hosts and the guests and 
through a series of actions brings them closer together), karakia (recognition of the 
spiritual), mihimihi (introductions that recognize where people come from and their 
connections to others), and poroporoakī (leave taking).  
 
Joan Metge, an anthropologist who has devoted her professional life to fostering 
understanding between Māori and non- Māori, has noted that Māori have adopted Pākehā 
(Anglo-Celtic) meeting strategies, but non-Māori have often ignored the values and rule 
governing discussion in Māori settings. Members of the ‘Constructive Conversations’ 
team have discussed how these cultural practices will inform the way we run focus 
groups with diverse participants, including all Māori groups, mixed Māori and non-Māori 
groups, and non-Māori groups. Issues surrounding tikanga Maori and the research 
process have been a central concern for Bevan Tipene-Matua, who heads the Maori 
Responsiveness team.  
 
We have also needed to conduct our own constructive conversations about the different 
ways in which members of the group define ‘deliberative democracy’ or ‘bioethics. At 
times we have encountered interesting differences between the approaches of 
philosophers, sociologists and biological scientists in the group, and between Māori and 
non-Māori members. The process of implementing the original design for the study has 
highlighted our diversity as team members, as well as our common purposes. These 
experiences will hopefully be important resources as we move to the next stage of the 
project – the piloting and implementation of the focus group methodology.  
 
Another key issue has been devising initiatives for discussion in the contact groups that 
facilitate multiple ways of framing issues relating to genetic testing. Dominant framing of 
the issues around genetic testing often focuses on consumer rights and issues individuals 
confront as they reflect on the personal implications of access the information about their 
genetic inheritance (See Petersen and Bunton, 2002 for discussion of the ways in which 
‘genetic citizenship’ is frequently constituted as the personal choices of individuals). 
                                                 
3 We are calling these focus groups ‘contact groups’ since they are seen as potentially ongoing nodes in the 
networks of group members who will all be contacted through their involvement in particular community 
organisations. 
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However, the team considers it important that research participants have the opportunity 
to reflect on more collective issues relating to genetic testing. These include priorities in 
the distribution of health care resources, the storage of genetic material from New 
Zealanders in overseas laboratories, the patenting of information about human genes, and 
the recording of medical histories and genetic information in commercial databases.  
 
Joanna Goven, who is responsible for coordinating the analysis of participants’ responses 
to the various interventions associated with the project, has highlighted the importance of 
facilitating opportunities for participants in dialogic processes to frame the issues (Goven, 
forthcoming). This has had an impact on the design of the contact group methodology 
and will also shape analysis of conversations in the contact groups. 
 
The need to ensure some consistency across contact groups in terms of the stimuli they 
receive to prompt discussion has also been balanced against the value of flexible formats 
for group discussion that allow participants to define issues and pose questions. While 
Māori cultural conventions for meetings will inform the processes used in each of the 
groups, the ways in which the practices of karakia, the consumption of food and 
poroporoakī are incorporated into the meeting will, of necessity, vary between different 
groups. How will non-Māori participants respond to being greeted in Māori? How will 
Māori participants respond to the relative formality of the show cards as prompts for 
discussion? How will members of Age Concern respond to the scenarios we present as 
opposed to Youthline counselors, Māori Mormon churchgoers, rugby club participants, 
iwi kuia and kaumātua (tribal elders), and members of the Cystic Fibrosis Foundation? 
 
The advantage of the ‘Constructive Conversations’ project (and other forms of publicly 
funded, but independent research in this field) is that it can pursue strategies for public 
participation in discussion about new health biotechnologies outside the pressures to 
produce material for particular policy decisions. At the same time, the research team has 
been funded to produce policy-relevant research. Not to attend to the timetabling of 
policy initiatives runs the risk of producing information that is unlikely to inform 
decision-making. One of the ongoing challenges for the research team will be to avoid 
being driven by government reviews of legislation and Select Committee deadlines, while 
at the same time being attentive to how the research can be useful to officials and 
politicians for whom these deadlines are crucial. 
 
Proliferating dialogue discourses 
 
The UK House of Lords Select Committee report on Science and Society indicated the 
need for ‘dialogue’ about science and technology. It advocated institutional mechanisms 
for contributions by diverse groups into the development of science policy (House of 
Lords, 2000). The UK report Science and Society report has been influential in the 
development of strategies by New Zealand government agencies directed at ‘dialogue’ 
(MoRST, 2001; 2002a; 2002b).  
 
Alan Irwin (2001: 3) argues that, in the last few years, ‘social scientific analyses have 
found a more attentive policy audience than has previously been the case in the UK’. This 
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attention to the potential value of social research for scientific and environmental policy 
has been mirrored in the New Zealand context. Increasing resources have become 
available to researchers interested in exploring how the rhetoric of dialogue might be 
translated into particular practices with different publics in relation to varied science and 
technology issues. These issues are as varied as waste management, pest control, genetic 
modification, biological weed management, genetic testing and the lifting of the 
moratorium on the commercial release of genetically modified organisms into the 
environment.  
 
The Science and Society attention to ‘dialogue’ is echoed in the statements of a number 
of the research teams contracted by the Foundation for Research, Science and 
Technology to produce information about the social, cultural, ethical and spiritual 
impacts’ of new biotechnologies. ‘Dialogue’ now has the status of a dominant discourse 
in the field of ‘science and society’ interventions. Scientists, clinicians and state officials 
are expected to act dialogically, rather than just to assume the authority that is often as 
associated with their professional status. Social researchers have responded to the 
challenges of providing evidence-based advice on how this dialogue can be achieved.  
 
The ‘Constructive Conversations’ project is just one of a number projects recently funded 
in Aotearoa/New Zealand that are directed at dialogue in the field of science and 
technology and a response to FRST requests for proposals on ‘the impact of new 
technologies’. It is complemented by another research team based at Waikato University 
that is similarly funded for five years to explore the social impacts of new 
biotechnologies. In the same funding round, another group of researchers at Otago and 
Massey Universities secured funding for survey of Māori responses to issues relating to 
genetic modification. It will involve conducting telephone interviews with over 200 
kaumātua and kuia (tribal elders). 
 
Earlier this year, the Ministry of Research, Science and Technology funded four research 
projects through its Science and Technology Dialogue Fund. This fund is directed at 
supporting experimentation with strategies directed at bringing together scientists and 
other stakeholders to talk about issues relating to science and technology (MoRST, 
2002b). The projects have preliminary funding for two years and an evaluation team has 
been commissioned to conduct a participatory evaluation with all the four teams. This 
will involve exploring the similar and different ways in which the teams set up their 
dialogue initiatives, implement the strategies they have developed, and move to some 
form of closure for the participants involved in the process. The research teams are 
located in both Crown Research Institutes and universities and will bring together a 
variety of different stakeholders. One of the most innovative endeavours combines the 
technology of The 7 Habits of Highly Effective People (Stephen Covey’s US based 
methodology for addressing personal and professional problems by becoming ‘principle 
centred’) with marae (Māori meeting place) procedures for discussions about alternative 
technologies for pest and weed management.   
 
Irwin has argued that, in the UK context, ‘“dialogue theory” currently has the upper hand 
over deficit theory’ (Irwin, 2001: 3). However, he goes on to note that there is little 
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experience in the UK of moving from attention to what the public does not know (the 
deficit model) to application of the principles of dialogue or interactive, multifaceted 
communication between scientists, policy makers and other members of the community. 
In the New Zealand context, the resources for work that address this gap have 
significantly expanded in the last few years. In this financial year (2003/4) publicly 
funded investment in GM and biotechnology impacts research is approximately $7 – 7.5 
million (NZ) per year. This exceeds the total amount available through Foundation for 
Research, Science and Technology in its ‘Social Research’ portfolio that currently stands 
about $6.592 million (MoRST, Vote Research, Science and Technology, 2003a, B.5 
Vol.ll:1079).  The ‘Social Research’ portfolio primarily includes research relating to 
family and children, community, ageing, housing, socio-economic disparities, migration 
and economic development.  
 
While investment on the impacts of new biotechnologies has significantly increased since 
2000, and particularly since 2002 in response to the recommendations of the Royal 
Commission on Genetic Modification, it is significantly less than public money spent on 
research using genetic modification as a research tool and research focused on developing 
new GM products.  About $134.5 million per annum was invested in 2002 in research 
relating to modern biotechnology and biotechnology-related research across the 
Foundation for Research, Science and Technology, the Health Research Council and the 
Royal Society of New Zealand (the Marsden Fund) (Biotechnology Task Force, 2003: 
28).  
 
Constraints on ‘scientific citizenship’? 
 
Irwin has argued that, while UK government agencies have embraced the rhetoric of 
dialogue and participation, the focus is primarily on how ‘public engagement will permit 
rather than impede scientific and technological development in areas such as 
biotechnology and biosciences’ (Irwin, 2001: 3). He predicts constraints on public 
dialogue about science, particularly if this form of deliberative democracy hinders 
innovation and commercial advantage. These are critical issues in the UK, but even more 
critical in Aotearoa/New Zealand where technological innovation in a diversifying 
economy is seen as essential to the maintenance of a fragile economy, which still rests 
heavy on the export of primary products (Office of the Prime Minister, 2002).  
 
The first significant investments in research directed at exploring the social impacts of 
new biotechnologies and public participation in scientific decision-making occurred in 
December 2000 while the Royal Commission on Genetic Modification (RCGM) was still 
in process. The Labour Government responses to the RCGM included a thorough review 
and public consultation process on the Hazardous Substances and New Organisms 
(HSNO) Act, the legislation used by the Environmental Risk Management Authority to 
regulate the use of genetically modified organisms as well as poisons, explosives and 
other hazardous substances. Amendments to that legislation are currently before a Select 
Committee.  
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The Government adopted the recommendation of the RCGM that it precede with caution 
with respect to the release of genetically modified organisms into the environment 
(Cabinet Policy Committee, 2001).  Since the Royal Commission reported in 2001, the 
Government has been creating the institutional and legislative environment necessary if it 
is to lift the moratorium on the commercial release of genetically modified organisms put 
in place when the RCGM was set up. While social researchers interested in this field are 
the beneficiaries of the Government’s decision to respond positively to the RCGM 
recommendations re social research, the research commissioned will not be available to 
inform the decision to lift the moratorium by the scheduled November deadline since 
most of it has only been commissioned in the last 1-2 years.   
 
One of the Government’s responses to the RCGM has been the establishment of the 
Bioethics Council, headed by an eminent Māori cleric and former Governor-General, Sir 
Paul Reeves (Ministry for the Environment, 2003). The Council will advise the 
Government on social, cultural, spiritual and ethical issues relating to new 
biotechnologies. It is currently engaged in research into public responses to the use of 
human genes in other organisms. It has also prepared submissions on Assisted Human 
Reproduction legislation currently before a Select Committee and amendments to the 
HSNO Act. The Bioethics Council is only an advisory body. It has no regulatory 
function, and owes its existence to a Cabinet Minute. This means that, while much is 
expected of the Council, its institutional existence is relatively fragile.  
 
The Government’s commitment to lifting of the moratorium by November 2003, and its 
increased funding for social research in this field, occurs in the context of support for 
biotechnology as a key component of its ‘Growth and Innovation Framework’ (Office of 
the Prime Minister, 2003). Biotechnology was identified early in 2002 as one of three 
areas that the Government wanted to target for development, and a taskforce consisting of 
stakeholders in the industry was established. They have recently reported to Government. 
The key recommendations are the need to build critical mass, to reform the regulatory 
framework to enhance competitiveness and to stimulate international investment in New 
Zealand biotech companies.  Their aim is to increase the number of biotechnology 
companies, boost export earnings, and treble the number of biotechnology organisations 
to more than 1,000 (Biotechnology Sector Taskforce, 2003). 
 
 The Labour Government has also recently released its Biotechnology Strategy, 
coordinated by the Ministry of Research Science and Technology (MoRST, 2003b). The 
development of the strategy was preceded by production of a discussion document for 
public consultation and the use of a variety of focus groups to get feedback on different 
dimensions of that preliminary document. The theme of the strategy is ‘development with 
care’. While the Biotechnology Strategy and the report of the Biotechnology Sector 
Taskforce both advocate growth in commercial uptake of biotechnology, the 
Biotechnology Strategy document attends more closely to ‘engagement with society’, the 
need for understanding ‘on both sides of diverse perspectives’ and the significance of 
attention to ethical and cultural concerns. It also embraces regulation to protect people 
and the environment and argues for the need to draw on Maori biological knowledge and 
innovative capacity as well as protecting traditional knowledge. 
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It is important to recognize that different government agencies or quasi-governmental 
organisations, such as the Office of the Commissioner for the Environment and the 
Bioethics Council, may have different orientations to public consultation. They may also 
have different ideas about the principles that should inform consultation and decision-
making, the place of regulation, and the ideal time frames for the development and use of 
new biotechnologies in the New Zealand context. While the Ministry of Research, 
Science and Technology may be very supportive of commercial development of science 
and technology, it nevertheless does have a responsibility to engage the public in debates 
about the biotechnologies and their impact on individuals and their environments.  
 
Scientific citizenship revisited 
 
Against the background of some of the tensions between the New Zealand Government’s 
interest in the development and application of new biotechnologies and its embrace of 
‘dialogue’, ‘consultation’ and ‘public participation’, what is the future of scientific 
citizenship in Aotearoa/New Zealand? Irwin has raised similar questions in the UK 
context. He asks: ‘Does dialogue imply that public knowledges are given the same status 
as scientific understandings – or instead that familiar deficit notions of an uninformed 
public are recycled? Who, for example, gets to decide what counts as a legitimate 
problem for discussion? How are informative (or information giving) and consultative (or 
information gathering) dimensions of participation to be balanced? What happens when 
public opinion is opposed to government policy – or, more likely, when certain shades of 
opinion are opposed, but others are in favour?’ (Irwin, 2001: 3). 
 
Irwin is reflecting on state initiatives, but these comments are equally pertinent to the 
work of a non-governmental research team, publicly funded to initiate and evaluate 
dialogue strategies for the discussion of emerging biotechnologies. The design of 
scenarios to be used in the first of the focus groups has involved balancing the 
‘information giving’ and ‘consultative’ dimensions of our research practice. We have 
sought to avoid ‘teacherly’ attempts at conveying information, but also wanted to provide 
participants with material to inform their responses to the scenarios they will be asked to 
discuss. At times we have also had to confront our own knowledge ‘deficit’, and avoid 
projecting it onto others. 
 
This project assumes that participants come with knowledge that is relevant to reflection 
on the social issues associated with health applications of new biotechnologies. That 
knowledge comes out of knowledge of Māori customary understandings and practices, 
ethical understandings accumulated by immigrants to this country over a lifetime, the 
practice of family relationships, and experiences of participants’ own illness or that of 
friends or family members. However, we are also interested in encouraging their own 
inquiries into these technologies and their communication with others in their social 
networks about genetic testing, xenotransplantation, and possibly bio-nanotechnology.  
 
We have constituted ourselves as those who will provide information useful to policy 
advisors, but we are also aware that advisors’ agendas must be shaped by the decisions 
 12
made at the level of Cabinet and pursued in the context of commercially driven 
innovation strategies. We know that we will be providing the insights of qualitative 
research in a context in which figures, graphs and tables are often important in 
convincing senior managers and Ministers of the value of particular research findings. 
 
Irwin argues that there is a need to move beyond ‘mere advocacy of scientific democracy 
and towards a more considered treatment of the possible forms of such democracy and 
their implications for wider publics’ (Irwin, 2001: 4). This is the focus of the 
‘Constructive Conversations’ project. In the next two years we will be experimenting 
with a particular set of strategies to facilitate public participation among diverse social 
actors in discussion of a range of issues relating to genetic testing. Evaluation of the 
outcome of these experiments (our own and those of other researchers and evaluators in 
the field), will inform the next stage of the project. This will involve interviews with 
those who are the most obvious stakeholders in the field and the facilitation of workshops 
that will involve all categories of research participants. Evaluation of this stage of the 
project will involve expanding on the range of biotechnologies discussed, and 
modification of the strategies for public engagement. We will also be evaluating 
responses to the website we are developing, both in terms of the number of hits, the web 
pages accessed and people’s comments on the site. We also hope to involve biological 
scientists associated with the New Zealand Institute for Genecology in the preparation of 
factual advice to participants who have indicated that they want more information about 
biotechnologies.  
 
Posing questions, resisting conclusions 
 
This paper has introduced an embryonic project, a project whose funding cannot be 
understood without attention to global initiatives to involve members of the public in 
conversations about science and technology in general, and biotechnologies in particular. 
It is a project that is pursued by independent researchers located in universities, 
polytechnics, publicly funded research institutes and private consultancies. At the same 
time it is funded by a public foundation that is charged with supporting research that will 
contribute information needed to inform policy advice.  
 
The Constructive Conversations proposal was evaluated on its potential relevance to key 
stakeholders and the connections between the research team and potential users of the 
research, but also on the basis of linkages to international researchers working in similar 
fields. Quality control by the Foundation of Research, Science and Technology demands 
of applicants that they are international in their orientation as well as local. For the 
project to receive funding it must therefore be simultaneously local and global.  
 
It is also important that this project is evaluated as a community intervention directed at 
public participation in the framing of policy issues and regulatory processes. It is fitting, 
given the stage of this research, to conclude this paper not with informed insights, but a 
set of questions.   How have other researchers negotiated this complex positioning as 
independent investigators and applied social researchers with responsibility to deliver 
relevant and timely information to key stakeholders? Do others in this workshop have 
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advice on how to draw members of community organisations into discussion of issues 
that on first appearance may not have direct relevance for their day-to-day operation, or 
provision of services to their members? How have other researchers managed to sustain 
involvement by participants in reconvened focus groups? How can we create the 
possibility of participation contributing to policy development without overselling the 
impact of evidence on policy, despite intensified calls for ‘evidence-based practice’? 
 
Forms of public consultation have become increasingly necessary to the legitimacy of 
social democracies, but governments, and those who advocate deliberative democracy, 
continue to encounter the challenges of delivering on the promise of participation. 
Addressing these challenges involves cross-national, cross-disciplinary communication 
that stretches the boundaries of the substantive fields in which researchers and change 
agents are located. This paper outlines an initiative by one set of actors in this process to 
participate in that conversation. 
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